Newsroom

Sorted by: Latest

-

DivcoWest Acquires Four-Building, Class A R&D Campus in San Jose, CA

SAN JOSE, Calif.--(BUSINESS WIRE)--DivcoWest, a DivCore Capital company, in a partnership with Grove Real Estate Partners, has purchased The Campus at Trimble, a 253,000 square foot R&D campus located at 375-441 West Trimble Road in North San Jose. Terms of the transaction, which was sourced and closed off-market, were not disclosed. Newmark represented the seller. “We are excited by the fundamentals underpinning high-quality R&D projects across Silicon Valley, particularly given the su...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: Corporacion Andina De Fomento USD 100,000,000.00 MATURING: 13-Jul-2026 ISIN: XS2649633463 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 14-Oct-2025 TO 13-Jan-2026 HAS BEEN FIXED AT 4.93 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 13-Jan-2026 WILL AMOUNT TO: USD 2,493.24 PER USD 200,000.00 DENOMINATION  ...
-

Kashiv BioSciences fera des présentations lors de la 44e conférence annuelle J.P. Morgan Healthcare

PISCATAWAY, New Jersey--(BUSINESS WIRE)--Kashiv BioSciences, LLC (« Kashiv »), une société biopharmaceutique verticalement intégrée, annonce aujourd’hui que le Dr Sandeep Athalye, CEO mondial, et le Dr Paras Vasanani, responsable du développement commercial, seront présents à la 44e conférence annuelle J.P. Morgan Healthcare à San Francisco, en Californie, le mercredi 14 janvier 2026, à 11h00 PST. 44e conférence annuelle J.P. Morgan Healthcare – présentation de Kashiv BioSciences Date : mercred...
-

Kashiv BioSciences participará en la 44.a Conferencia Anual de J.P. Morgan Healthcare

PISCATAWAY, Nueva Jersey--(BUSINESS WIRE)--Kashiv BioSciences, LLC («Kashiv»), empresa biofarmacéutica integrada verticalmente, acaba de anunciar que el Dr. Sandeep Athalye, director ejecutivo global, y el Dr. Paras Vasanani, director de Desarrollo Empresarial, ofrecerán una ponencia en la 44.ª Conferencia Anual de J.P. Morgan Healthcare, que se celebrará en San Francisco, California, el miércoles 14 de enero de 2026, a las 11:00 (Hora Estándar del Pacífico). 44.a Conferencia Anual de J.P. Morg...
-

Kashiv BioSciences sarà presente alla 44ª conferenza annuale sulla sanità di J.P. Morgan

PISCATAWAY, NEW JERSEY--(BUSINESS WIRE)--Kashiv BioSciences, LLC ("Kashiv"), un'azienda biofarmaceutica integrata verticalmente, ha annunciato oggi che Sandeep Athalye, Global Chief Executive Officer, e Paras Vasanani, Direttore per il Business Development, presenteranno la 44ª conferenza annuale sulla sanità di J.P. Morgan a San Francisco, in California, mercoledì 14 gennaio 2026, alle 11:00 PST. Presentazione della 44ª conferenza annuale sulla sanità di J.P. Morgan – Kashiv BioSciences Data:...
-

Kashiv BioSciences präsentiert sich auf der 44. jährlichen J.P. Morgan Healthcare Conference

PISCATAWAY, New Jersey--(BUSINESS WIRE)--Kashiv BioSciences, LLC („Kashiv“), ein vertikal integriertes biopharmazeutisches Unternehmen, gab heute bekannt, dass Dr. Sandeep Athalye, Global Chief Executive Officer, und Dr. Paras Vasanani, Leiter der Geschäftsentwicklung, am Mittwoch, dem 14. Januar 2026, um 11:00 Uhr PST auf der 44. jährlichen J.P. Morgan Healthcare Conference in San Francisco, Kalifornien, präsentieren werden. 44. jährliche J.P. Morgan Healthcare Conference – Unternehmenspräsent...
-

Kashiv BioSciences zal aanwezig zijn tijdens de 44e Annual J.P. Morgan Healthcare Conference

PISCATAWAY, N.J.--(BUSINESS WIRE)--Kashiv BioSciences, LLC (“Kashiv”), een verticaal geïntegreerd biofarmaceutisch bedrijf, maakte vandaag bekend dat Dr. Sandeep Athalye, internationale CEO, en Dr. Paras Vasanani, Hoofd Bedrijfsontwikkeling, aanwezig zullen zijn tijdens de 44e Annual J.P. Morgan Healthcare Conference in San Francisco, Californië, op woensdag 14 januari 2026, om 11.00 uur a.m. PST. 44e Annual J.P. Morgan Healthcare Conference – Bedrijfspresentatie van Kashiv BioSciences Datum: w...
-

HRL Laboratories Earns Best Place to Work Spot for Fourth Year

MALIBU, Calif.--(BUSINESS WIRE)--For the fourth year in a row, HRL Laboratories was recognized in Built In’s 2026 Best Places to Work Awards. Specifically, HRL was honored in the following categories: Best Places to Work in Los Angeles Best Large Companies in Los Angeles The annual awards honor employers across the U.S. whose benefits and compensation set the standard for today’s workforce. “By helping our employees grow, lead and succeed, we consistently earn high marks for being a top place t...
-

Mickalene Thomas Named HELP USA’s 2026 Art of Resilience Artist

NEW YORK--(BUSINESS WIRE)--HELP USA today announced that internationally acclaimed contemporary artist Mickalene Thomas has been named 2026 Art of Resilience Artist. Thomas will create a permanent, site-specific mural for a newly built families-with-children transitional shelter in the Highbridge section of the Bronx, marking a significant collaboration between the artist and the national housing and homeless services provider. Art of Resilience, launched in 2022, is HELP USA’s trauma-informed...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: Lloyds Bank Corporate Markets plc EUR 40,000,000.00 MATURING: 08-Jul-2027 ISIN: XS3113263258 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 08-Jan-2026 TO 08-Apr-2026 HAS BEEN FIXED AT 2.46 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 08-Apr-2026 WILL AMOUNT TO: EUR 614.00 PER EUR 100,000.00 DENOMINATION  ...